<DOC>
	<DOCNO>NCT02390297</DOCNO>
	<brief_summary>Long term safety follow-up Cal-1 recipient</brief_summary>
	<brief_title>Long Term Follow Detection Delayed Adverse Events Cal-1 Recipients</brief_title>
	<detailed_description>Long Term Follow-up Detection Delayed Adverse Events Recipients CD4+ T Lymphocytes and/or CD34+ Hematopoietic Stem/Progenitor Cells Transduced LVsh5/C46 ( Cal-1 ) , Dual Anti-HIV Gene Transfer Construct</detailed_description>
	<criteria>Signed informed consent Previous treatment Cal1 modify hematopoietic cellular product Inability understand provide inform consent</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>